0.0175
0.0000
(0.00%)
At close: January 28 at 8:11:33 AM GMT+1
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Benjamin Lightburn | Co-Founder, CEO & Chairman | 119.94k | -- | 1987 |
| Ms. Lisa Ranken | Chief Operating Officer | 86.48k | -- | 1984 |
| Mr. Ryan Moss | Chief Science Officer | 75.37k | -- | -- |
| Mr. Jonathan Conlin | Corporate Secretary & Director | -- | -- | 1985 |
| Mr. Steven Nguyen CPA | Interim Chief Financial Officer | -- | -- | 1994 |
| Ms. Anna Cordon | Vice President of Marketing & Communications | -- | -- | -- |
| Mr. Jeff Fellows | Head of Regulatory | -- | -- | -- |
| Andry Tjahyana | VP of Business Development | 126.4k | -- | -- |
| Sara Burke B.A., M.B.A. | Head of Global Partnerships | -- | -- | -- |
Filament Health Corp.
4475 Wayburne Drive
Unit 210
Burnaby, BC V5G 4X4
Canada
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 13
Description
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. Its leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. The company also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, it provides in-house human clinical trials, as well as license technology to drug developers, researchers, and other licensed parties. Filament Health Corp. is headquartered in Burnaby, Canada.
Corporate Governance
Filament Health Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available